Oura IPO seeks $2.2bn as 73% goes to existing shareholders

Oura’s IPO values the smart ring maker at $14.1bn, with a significant portion of the capital flowing directly to early investors rather than the company itself. The Finnish technology firm launched its initial public offering on the Nasdaq Global Select Market under the ticker symbol OURA. It is marketing 50 million shares priced between $40 and $44 each. At the upper end of that range, the transaction raises approximately $2.2 billion.

The structure of this deal highlights an unusual dynamic where existing stockholders are the primary beneficiaries. Of the 50 million shares being sold, Oura is issuing only 13.5 million new shares. The remaining 36.5 million shares belong to current shareholders who are cashing out. This ratio becomes even more skewed if the underwriters exercise their 30-day over-allotment option for an additional 7.5 million shares, which also goes entirely to selling stockholders.

At the top of the price range, Oura will retain roughly $594 million after fees. In contrast, existing shareholders stand to collect about $1.61 billion, representing 73% of the base deal proceeds. If the over-allotment is fully exercised, selling stockholders would take close to $1.94 billion of a $2.53 billion total, or 77% of the deal. The company’s filing explicitly states: “Oura will not receive any proceeds from the sale of its common stock by the selling stockholders.” While cash-outs are common in late-stage listings, the proportion of capital going to insiders rather than the corporate balance sheet is notable.

Strategic Buybacks Drive Flotation Timing

The decision to go public now follows a massive internal restructuring. During the first nine months of its fiscal year, ending June 30, Oura spent $1.17 billion repurchasing its own shares from investors. This included a tender offer in February for 13,295,528 preferred shares at $40.18 each. To fund these buybacks, the company drew $375 million from a revolving credit facility.

These aggressive share repurchases have significantly impacted the company’s financial reporting. The filing reveals a net loss attributable to common stockholders of $924.3 million. However, this figure is largely driven by a $985 million deemed dividend paid to preferred holders, which converted the operating business’s $60.8 million net income into a reported loss. By the end of June, Oura held $371.8 million in cash against a stockholders’ deficit of $1.62 billion.

This context suggests the IPO is effectively the second half of a transaction that began in February. Oura bought out early investors at $40.18 per share and is now offering the same equity to the public market at a comparable price point. The valuation has adjusted downward from earlier reports. In August, Bloomberg noted targets up to $3 billion, implying a valuation above $16 billion. The current launch represents a roughly 27% reduction in the ask and a valuation approximately $2 billion lower. Despite this drop, the debut valuation of $14.1 billion remains 29% higher than the $10.9 billion valuation set during its Series E round last September.

Membership Growth and Warranty Risks

Bankers are pitching the company’s recurring revenue model rather than hardware sales alone. Membership revenue surged 121% to $240.5 million over the nine-month period, outpacing hardware growth of 65%. The membership segment boasts an impressive gross margin of 89%. Conversion rates are strong, with roughly 94% of ring buyers subscribing to a paid plan and 85% retaining that subscription after one year. Sixty-three percent opt for annual billing.

In its updated S-1 filing, Oura guided toward approximately 5.7 million paid members by the end of fiscal 2026. This target implies 96% year-on-year growth. With 5.0 million members recorded at the end of June, the guidance requires adding roughly 700,000 new subscribers in the final quarter. The company attributes this momentum to the launch of the Oura Ring 5 in May. Over the trailing twelve months, Oura sold approximately 3.6 million rings, capturing about 2% of the global wearables market. Notably, Eli Lilly’s $50 million investment converts to stock at the IPO pricing.

However, the risk section of the filing outlines two concrete challenges. First, warranty costs are substantial. Oura booked $84.4 million in warranty expense in fiscal 2025 and carried an accrual of $132.3 million as of June 30. Having paid out $75.5 million in claims over nine months, these liabilities represent a significant operational cost relative to the 3.1 million rings sold in that period.

Second, the company faces legal scrutiny regarding data accuracy. A proposed class action in the Northern District of California challenges Oura’s claim of 95% sleep staging accuracy compared to clinical sleep labs. The lawsuit cites research involving 45 patients that found overall classification accuracy at just 53.18%. Oura disputes these findings, stating: “We stand behind our science, research, and accuracy claims.” The company points to independent studies comparing its staging favorably with polysomnography. The suit names both Oura Inc. and its Finnish parent, Oura Health Oy.

Syndicate Structure and European Context

The banking syndicate for the IPO is extensive, featuring major institutions such as Goldman Sachs, Morgan Stanley, J. P. Morgan, Allen & Company, and Jefferies as joint lead book-running managers. BofA Securities, Barclays, and Wells Fargo Securities serve as senior managers, followed by Citizens, KeyBanc, and Guggenheim. Six additional firms round out the group.

Uniquely, the retail brokerage Robinhood appears in the syndicate list, but solely as a co-manager at the bottom tier. This placement was visible in the S-1 filing two weeks prior and remained unchanged through the launch.

Founded in Finland in 2013, Oura maintains its EU headquarters in Oulu while its corporate headquarters is located in San Francisco. The move to list on Nasdaq mirrors strategies adopted by other European tech giants like Revolut and Anthropic. This trend of European companies raising public capital in the United States continues to draw attention from policymakers who view it as a structural issue for the region. The true test for Oura will not be its first day of trading, but whether it can hit its ambitious member growth target while managing the tangible costs of warranties and legal challenges as it reports its first results as a public entity.